Tylenol-maker Kenvue’s stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials
via fortune.com
Short excerpt below. Read at the original source.
A pending announcement from the Trump administration linking pain relief drug acetaminophen with autism has stirred investor anxiety in the drug’s primary producer. The share price of Kenvue, the parent company of Tylenol, is down more than 5% on Monday following President Donald Trump’s comments that acetaminophen is “a very big factor” for the risk […]